Works matching AU Colombo, Nicoletta


Results: 99
    1
    2

    Early CAR<sup>−</sup> CD4<sup>+</sup> T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma.

    Published in:
    EJHaem, 2024, v. 5, n. 2, p. 360, doi. 10.1002/jha2.871
    By:
    • Gambella, Massimiliano;
    • Carlomagno, Simona;
    • Mangerini, Rosa;
    • Colombo, Nicoletta;
    • Parodi, Alessia;
    • Ghiggi, Chiara;
    • Giannoni, Livia;
    • Coviello, Elisa;
    • Setti, Chiara;
    • Luchetti, Silvia;
    • Serio, Alberto;
    • Laudisi, Antonella;
    • Passannante, Monica;
    • Bo, Alessandra;
    • Tedone, Elisabetta;
    • Sivori, Simona;
    • Angelucci, Emanuele;
    • Raiola, Anna Maria
    Publication type:
    Article
    3
    4
    5

    A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 12, p. e2254, doi. 10.1002/onco.13971
    By:
    • OZA, AMIT M.;
    • DUBOIS, FRANÇOIS;
    • HEGG, ROBERTO;
    • HERNÁNDEZ, CARLOS ALBERTO;
    • FINOCCHIARO, GAETANO;
    • GHIRINGHELLI, FRANÇOIS;
    • ZAMAGNI, CLAUDIO;
    • NICK, SONJA;
    • IRAHARA, NATSUMI;
    • PERRETTI, THOMAS;
    • COLOMBO, NICOLETTA
    Publication type:
    Article
    6

    A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

    Published in:
    Oncologist, 2020, v. 25, n. 2, p. e311, doi. 10.1634/theoncologist.2019-0309
    By:
    • Macchia, Gabriella;
    • Lazzari, Roberta;
    • Colombo, Nicoletta;
    • Laliscia, Concetta;
    • Capelli, Giovanni;
    • D'Agostino, Giuseppe Roberto;
    • Deodato, Francesco;
    • Maranzano, Ernesto;
    • Ippolito, Edy;
    • Ronchi, Sara;
    • Paiar, Fabiola;
    • Scorsetti, Marta;
    • Cilla, Savino;
    • Ingargiola, Rossana;
    • Huscher, Alessandra;
    • Cerrotta, Anna Maria;
    • Fodor, Andrei;
    • Vicenzi, Lisa;
    • Russo, Donatella;
    • Borghesi, Simona
    Publication type:
    Article
    7

    Systems epigenetic approach towards non-invasive breast cancer detection.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-53696-2
    By:
    • Herzog, Chiara M. S.;
    • Theeuwes, Bente;
    • Jones, Allison;
    • Evans, Iona;
    • Bjørge, Line;
    • Zikan, Michal;
    • Cibula, David;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Pashayan, Nora;
    • Widschwendter, Martin
    Publication type:
    Article
    8
    9

    Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.

    Published in:
    2019
    By:
    • Colombo, Nicoletta;
    • Zaccarelli, Eleonora;
    • Baldoni, Alessandra;
    • Frezzini, Simona;
    • Scambia, Giovanni;
    • Palluzzi, Eleonora;
    • Tognon, Germana;
    • Lissoni, Andrea A.;
    • Rubino, Daniela;
    • Ferrero, Annamaria;
    • Farina, Gabriella;
    • Negri, Emanuele;
    • Pesenti Gritti, Angela;
    • Galli, Francesca;
    • Biagioli, Elena;
    • Rulli, Eliana;
    • Poli, Davide;
    • Gerardi, Chiara;
    • Torri, Valter;
    • Fossati, Roldano
    Publication type:
    journal article
    10

    A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

    Published in:
    British Journal of Cancer, 2018, v. 119, n. 5, p. 565, doi. 10.1038/s41416-018-0190-y
    By:
    • Gadducci, Angiolo;
    • Grosso, Federica;
    • Scambia, Giovanni;
    • Raspagliesi, Francesco;
    • Colombo, Nicoletta;
    • Grignani, Giovanni;
    • Casali, Paolo;
    • Sanfilippo, Roberta;
    • Buonadonna, Angela;
    • Santoro, Armando;
    • Bruzzone, Milena;
    • Artioli, Grazia;
    • Lorusso, Domenica;
    • Biagioli, Elena;
    • Fossati, Roldano;
    • Galli, Francesca;
    • Negri, Emanuele;
    • Rulli, Eliana;
    • Torri, Valter;
    • D’Incalci, Maurizio
    Publication type:
    Article
    11

    A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

    Published in:
    2018
    By:
    • Gadducci, Angiolo;
    • Grosso, Federica;
    • Scambia, Giovanni;
    • Raspagliesi, Francesco;
    • Colombo, Nicoletta;
    • Grignani, Giovanni;
    • Casali, Paolo;
    • Sanfilippo, Roberta;
    • Buonadonna, Angela;
    • Santoro, Armando;
    • Bruzzone, Milena;
    • Artioli, Grazia;
    • Lorusso, Domenica;
    • Biagioli, Elena;
    • Fossati, Roldano;
    • Galli, Francesca;
    • Negri, Emanuele;
    • Rulli, Eliana;
    • Torri, Valter;
    • D'Incalci, Maurizio
    Publication type:
    journal article
    12
    13

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    14
    15

    High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 755, doi. 10.1002/ajh.24391
    By:
    • Guolo, Fabio;
    • Minetto, Paola;
    • Clavio, Marino;
    • Miglino, Maurizio;
    • Di Grazia, Carmen;
    • Ballerini, Filippo;
    • Pastori, Giordana;
    • Guardo, Daniela;
    • Colombo, Nicoletta;
    • Kunkl, Annalisa;
    • Fugazza, Giuseppina;
    • Rebesco, Barbara;
    • Sessarego, Mario;
    • Lemoli, Roberto Massimo;
    • Bacigalupo, Andrea;
    • Gobbi, Marco
    Publication type:
    Article
    16
    17

    Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study.

    Published in:
    Medical Oncology, 2014, v. 31, n. 8, p. 1, doi. 10.1007/s12032-014-0076-7
    By:
    • Sehouli, Jalid;
    • Pietzner, Klaus;
    • Wimberger, Pauline;
    • Vergote, Ignace;
    • Rosenberg, Per;
    • Schneeweiss, Andreas;
    • Bokemeyer, Carsten;
    • Salat, Christoph;
    • Scambia, Giovanni;
    • Berton-Rigaud, Dominique;
    • Santoro, Armando;
    • Cervantes, Andrés;
    • Trédan, Olivier;
    • Tournigand, Christophe;
    • Colombo, Nicoletta;
    • Dudnichenko, Alexander;
    • Westermann, Anneke;
    • Friccius-Quecke, Hilke;
    • Lordick, Florian
    Publication type:
    Article
    18
    19

    The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27918-w
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Jones, Allison;
    • Leavy, Olivia C.;
    • Evans, Iona;
    • Knapp, Susanne;
    • Reisel, Daniel;
    • Nazarenko, Tatiana;
    • Kim, Yoo-Na;
    • Franchi, Dorella;
    • Ryan, Andy;
    • Franks, Joanna;
    • Bjørge, Line;
    • Zikan, Michal;
    • Cibula, David;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Dudbridge, Frank;
    • Jones, Louise;
    • Sundström, Karin
    Publication type:
    Article
    20

    WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 10, p. 1961, doi. 10.3109/10428194.2011.585673
    By:
    • Miglino, Maurizio;
    • Colombo, Nicoletta;
    • Pica, Gianmatteo;
    • Grasso, Raffaella;
    • Clavio, Marino;
    • Bergamaschi, Micaela;
    • Ballerini, Filippo;
    • Ghiso, Anna;
    • Ghiggi, Chiara;
    • Mitscheunig, Laura;
    • Beltrami, Germana;
    • Cagnetta, Antonia;
    • Vignolo, Luana;
    • Lucchetti, Maria Vita;
    • Aquino, Sara;
    • Pierri, Ivana;
    • Sessarego, Mario;
    • Carella, Angelo Michele;
    • Gobbi, Marco
    Publication type:
    Article
    21
    22
    23

    PB1742: FEASIBILITY AND EFFICACY OF A PEG‐ASPARAGINASE‐BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA‐NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000973828.01091.37
    By:
    • Vernarecci, Chiara;
    • Ferro, Beatrice;
    • Puglisi, Francesco;
    • Nurra, Clara;
    • Carminati, Enrico;
    • Riva, Carola;
    • Chies, Maria;
    • Maio, Elena;
    • Zecchetti, Giada;
    • Miglino, Maurizio;
    • Colombo, Nicoletta;
    • Ballerini, Filippo;
    • Cagnetta, Antonia;
    • Cea, Michele;
    • Tedone, Elisabetta;
    • Guolo, Fabio;
    • Minetto, Paola;
    • Lemoli, Roberto Massimo
    Publication type:
    Article
    24

    P381: FULL PEDIATRIC INDUCTION IN ADULTS AGED UP TO 55 YEARS WITH PHILADELPHIA‐NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IS WELL TOLERATED AND RESULTS IN VERY HIGH CURE RATE.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000968432.77140.84
    By:
    • Maio, Elena;
    • Montanari, Mattia;
    • Puglisi, Francesco;
    • Nurra, Clara;
    • Miglino, Maurizio;
    • Colombo, Nicoletta;
    • Carminati, Enrico;
    • Zecchetti, Giada;
    • Vernarecci, Chiara;
    • Chies, Maria;
    • Ferro, Beatrice;
    • Zucchetti, Massimo;
    • Cagnetta, Antonia;
    • Cea, Michele;
    • Tedone, Elisabetta;
    • Massimo Lemoli, Roberto;
    • Guolo, Fabio;
    • Minetto, Paola
    Publication type:
    Article
    25

    P530: CPX-351 INDUCTION IS ABLE TO INDUCE MRD NEGATIVE CR IN A SIGNIFICATIVE PROPORTION OF VERY HIGH RISK AML PATIENTS, REGARDLESS OF MUTATIONAL BURDEN, ALLOWING FOR BRIDGING TO TRANSPLANTATION.

    Published in:
    2023
    By:
    • Riva, Carola;
    • Chies, Maria;
    • Minetto, Paola;
    • Vernarecci, Chiara;
    • Maio, Elena;
    • Ferro, Beatrice;
    • Zecchetti, Giada;
    • Miglino, Maurizio;
    • Tedone, Elisabetta;
    • Colombo, Nicoletta;
    • Carminati, Enrico;
    • Nurra, Clara;
    • Puglisi, Francesco;
    • Cagnetta, Antonia;
    • Cea, Michele;
    • Massimo Lemoli, Roberto;
    • Guolo, Fabio
    Publication type:
    Abstract
    26

    The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

    Published in:
    Journal of the Peripheral Nervous System, 2007, v. 12, n. 3, p. 210, doi. 10.1111/j.1529-8027.2007.00141.x
    By:
    • Cavaletti, Guido;
    • Frigeni, Barbara;
    • Lanzani, Francesca;
    • Piatti, Marialuisa;
    • Rota, Stefania;
    • Briani, Chiara;
    • Zara, Gabriella;
    • Plasmati, Rosaria;
    • Pastorelli, Francesca;
    • Caraceni, Augusto;
    • Pace, Andrea;
    • Manicone, Mariagrazia;
    • Lissoni, Andrea;
    • Colombo, Nicoletta;
    • Bianchi, Giulia;
    • Zanna, Claudio
    Publication type:
    Article
    27

    Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1695, doi. 10.1080/10428194.2020.1737685
    By:
    • Guolo, Fabio;
    • Minetto, Paola;
    • Clavio, Marino;
    • Marcolin, Riccardo;
    • Miglino, Maurizio;
    • Passannante, Monica;
    • Caviglia, Fabrizio;
    • Ballerini, Filippo;
    • Tedone, Elisabetta;
    • Kunkl, Annalisa;
    • Mangerini, Rosa;
    • Contini, Paola;
    • Colombo, Nicoletta;
    • Cagnetta, Antonia;
    • Cea, Michele;
    • Carminati, Enrico;
    • Pugliese, Girolamo;
    • Gobbi, Marco;
    • Lemoli, Roberto Massimo
    Publication type:
    Article
    28

    Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 11, p. 2214, doi. 10.3109/10428194.2012.681658
    By:
    • Miglino, Maurizio;
    • Colombo, Nicoletta;
    • Grasso, Raffaella;
    • Marani, Carlo;
    • Clavio, Marino;
    • Pica, Gian Matteo;
    • Ballerini, Filippo;
    • Ghiggi, Chiara;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Carella, Angelo Michele;
    • Gobbi, Marco
    Publication type:
    Article
    29

    Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression.

    Published in:
    British Journal of Haematology, 2013, v. 160, n. 4, p. 503, doi. 10.1111/bjh.12181
    By:
    • Pozzi, Sarah;
    • Geroldi, Simona;
    • Tedone, Elisabetta;
    • Luchetti, Silvia;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Di Grazia, Carmen;
    • Lamparelli, Teresa;
    • Gualandi, Francesca;
    • Ibatici, Adalberto;
    • Bregante, Stefania;
    • Lint, Maria Teresa;
    • Raiola, Anna Maria;
    • Dominietto, Alida;
    • Varaldo, Riccardo;
    • Signori, Alessio;
    • Bacigalupo, Andrea
    Publication type:
    Article
    30
    31

    Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.

    Published in:
    International Journal of Cancer, 1995, v. 60, n. 3, p. 300, doi. 10.1002/ijc.2910600304
    By:
    • Bernasconi, Sergio;
    • Matteucci, Christian;
    • Sironi, Marina;
    • Conni, Mario;
    • Colotta, Francesco;
    • Mosca, Monica;
    • Colombo, Nicoletta;
    • Bonazzi, Cristina;
    • Landoni, Fabio;
    • Corbetta, Giuseppe;
    • Mantovani, Alberto;
    • Allavena, Paola
    Publication type:
    Article
    32
    33

    Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study.

    Published in:
    Journal of Ovarian Research, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13048-022-00970-w
    By:
    • Mosconi, Paola;
    • Roberto, Anna;
    • Cerana, Nicoletta;
    • Colombo, Nicoletta;
    • Didier, Florence;
    • D'Incalci, Maurizio;
    • Lorusso, Domenica;
    • Peccatori, Fedro Alessandro;
    • Network of Clinicians and Participants (1);
    • Artioli, Grazia;
    • Cavanna, Luigi;
    • Ceccherini, Rita;
    • Cirigliano, Giovanna;
    • Comerci, Giuseppe;
    • Cormio, Gennaro;
    • Crippa, Alessandra;
    • Farolfi, Alberto;
    • Febbraro, Antonio;
    • Giardina, Donatella;
    • Greggi, Stefano
    Publication type:
    Article
    34
    35

    Comparing Outcomes Between CPX‐351 and Fludarabine‐Based Induction in Secondary Acute Myeloid Leukemia in the Real‐World Setting: The Prognostic Role of Measurable Residual Disease.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70005
    By:
    • Riva, Carola;
    • Minetto, Paola;
    • Chies, Maria;
    • Vernarecci, Chiara;
    • Colombo, Nicoletta;
    • Rosellini, Sara;
    • Parodi, Alessia;
    • Tedone, Elisabetta;
    • Carminati, Enrico;
    • Nurra, Clara;
    • Puglisi, Francesco;
    • Frello, Michela;
    • Maio, Elena;
    • Ferro, Beatrice;
    • Zecchetti, Giada;
    • Fugazza, Giuseppina;
    • Nozza, Paolo;
    • Cea, Michele;
    • Lemoli, Roberto Massimo;
    • Guolo, Fabio
    Publication type:
    Article
    36
    37

    Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3 -ITD in NPM1 Mutated AML, Irrespectively of FLT3 -ITD Allelic Burden.

    Published in:
    Cancers, 2021, v. 13, n. 1, p. 34, doi. 10.3390/cancers13010034
    By:
    • Minetto, Paola;
    • Candoni, Anna;
    • Guolo, Fabio;
    • Clavio, Marino;
    • Zannier, Maria Elena;
    • Miglino, Maurizio;
    • Dubbini, Maria Vittoria;
    • Carminati, Enrico;
    • Sicuranza, Anna;
    • Ciofini, Sara;
    • Colombo, Nicoletta;
    • Pugliese, Girolamo;
    • Marcolin, Riccardo;
    • Santoni, Adele;
    • Ballerini, Filippo;
    • Lanino, Luca;
    • Cea, Michele;
    • Gobbi, Marco;
    • Bocchia, Monica;
    • Fanin, Renato
    Publication type:
    Article
    38
    39

    The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.

    Published in:
    EMBO Molecular Medicine, 2011, v. 3, n. 8, p. 480, doi. 10.1002/emmm.201100152
    By:
    • Zecchini, Silvia;
    • Bombardelli, Lorenzo;
    • Decio, Alessandra;
    • Bianchi, Marco;
    • Mazzarol, Giovanni;
    • Sanguineti, Fabio;
    • Aletti, Giovanni;
    • Maddaluno, Luigi;
    • Berezin, Vladimir;
    • Bock, Elisabeth;
    • Casadio, Chiara;
    • Viale, Giuseppe;
    • Colombo, Nicoletta;
    • Giavazzi, Raffaella;
    • Cavallaro, Ugo
    Publication type:
    Article
    40
    41

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    42

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    43

    Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.

    Published in:
    Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02603-3
    By:
    • Barrett, James E.;
    • Herzog, Chiara;
    • Kim, Yoo-Na;
    • Bartlett, Thomas E.;
    • Jones, Allison;
    • Evans, Iona;
    • Cibula, David;
    • Zikan, Michal;
    • Bjørge, Line;
    • Harbeck, Nadia;
    • Colombo, Nicoletta;
    • Howell, Sacha J.;
    • Rådestad, Angelique Flöter;
    • Gemzell-Danielsson, Kristina;
    • Widschwendter, Martin
    Publication type:
    Article
    44
    45

    De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".

    Published in:
    2013
    By:
    • Clavio, Marino;
    • Cruciani, Fabio;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Ballerini, Filippo;
    • Marani, Carlo;
    • De Astis, Enrico;
    • Aquino, Sara;
    • Bergamaschi, Micaela;
    • Mitscheunig, Laura;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Ghiggi, Chiara;
    • Lovera, Davide;
    • Pastori, Giordana;
    • Avenoso, Daniele;
    • Miglino, Maurizio;
    • Gobbi, Marco
    Publication type:
    journal article
    46

    De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.

    Published in:
    Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
    By:
    • Clavio, Marino;
    • Cruciani, Fabio;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Ballerini, Filippo;
    • Marani, Carlo;
    • De Astis, Enrico;
    • Aquino, Sara;
    • Bergamaschi, Micaela;
    • Mitscheunig, Laura;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Ghiggi, Chiara;
    • Lovera, Davide;
    • Pastori, Giordana;
    • Avenoso, Daniele;
    • Miglino, Maurizio;
    • Gobbi, Marco
    Publication type:
    Article
    47
    48

    Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 20, p. 7162, doi. 10.1002/cam4.4260
    By:
    • Oaknin, Ana;
    • Oza, Amit M.;
    • Lorusso, Domenica;
    • Aghajanian, Carol;
    • Dean, Andrew;
    • Colombo, Nicoletta;
    • Weberpals, Johanne I.;
    • Clamp, Andrew R.;
    • Scambia, Giovanni;
    • Leary, Alexandra;
    • Holloway, Robert W.;
    • Amenedo Gancedo, Margarita;
    • Fong, Peter C.;
    • Goh, Jeffrey C.;
    • O'Malley, David M.;
    • Armstrong, Deborah K.;
    • Banerjee, Susana;
    • García‐Donas, Jesus;
    • Swisher, Elizabeth M.;
    • Cameron, Terri
    Publication type:
    Article
    49
    50